FDA Overseas Clinical Trial Tracking, IRB Inspections Suggested By IG
Executive Summary
FDA should consider incorporating overseas clinical trial tracking capabilities into domestic databases currently under development, an HHS Office of the Inspector General report suggests.
You may also be interested in...
FDA Foreign Trials Proposed Rule Drops Reliance On Helsinki Declaration
FDA is proposing to revise its requirements for accepting data from foreign trials not conducted under an IND
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011